CRON
Cronos Group, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$3.25
+1.25%Forward multiples
Based on analyst estimates
- P/E forward
- 15.00x
- P/E 2026E
- 21.41x
- P/E 2027E
- 20.67x
- P/E 2028E
- 17.47x
- P/S forward
- 4.40x
Trailing multiples
Trailing twelve months
- P/E TTM
- 17.93x
- PEG TTM
- 0.92x
- Price / book
- 1.12x
- Price / sales
- 5.32x
- Price / cash flow
- 19.92x
Enterprise value
- Enterprise value
- $450.4M
- EV / sales
- 2.00x
- EV / EBITDA
- 39.65x
- EV / EBIT
- 35.64x
- Market cap
- $1.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026